Perineural invasion is an independent predictor of outcome in colorectal cancer

Catherine Liebig, Gustavo Ayala, Jonathan Wilks, Gordana Verstovsek, Hao Liu, Neeti Agarwal, David H. Berger, Daniel Albo

Research output: Contribution to journalArticle

199 Citations (Scopus)

Abstract

Purpose: Perineural invasion (PNI) is associated with decreased survival in several malignancies, but its significance in colorectal cancer (CRC) remains to be clearly defined. We evaluated PNI as a potential prognostic indicator in CRC, focusing on its significance in node-negative patients. Patients and Methods: We identified 269 consecutive patients who had CRC resected at our institution. Tumors were rereviewed for PNI by a pathologist blinded to the patients' outcomes. Overall and disease-free survivals were determined using the Kaplan-Meier method, with differences determined by multivariate analysis using the Cox multiple hazards model. Results were compared using the log-rank test. Results: PNI was identified in less than 0.5% of the initial pathology reports. On rereview, 22% of tumors in our series were found to be PNI positive. The 5-year disease-free survival rate was four-fold greater for patients with PNI-negative tumors versus those with PNI-positive tumors (65% v 16%, respectively; P < .0001). The 5-year overall survival rate was 72% for PNI-negative tumors versus 25% for PNI-positive tumors. On multivariate analysis, PNI was an independent prognostic factor for both cancer-specific overall and disease-free survival. In a subset analysis comparing patients with node-negative disease with patients with stage III disease, the 5-year disease-free survival rate was 56% for stage III patients versus 29% for patients with node-negative, PNI-positive tumors (P = .0002). Similar results were seen for overall survival. Conclusion: PNI is grossly underreported in CRC and could serve as an independent prognostic factor of outcomes in these patients. PNI should be considered when stratifying CRC patients for adjuvant treatment.

Original languageEnglish (US)
Pages (from-to)5131-5137
Number of pages7
JournalJournal of Clinical Oncology
Volume27
Issue number31
DOIs
StatePublished - Nov 1 2009
Externally publishedYes

Fingerprint

Colorectal Neoplasms
Neoplasms
Disease-Free Survival
Survival Rate
Multivariate Analysis
Survival
Proportional Hazards Models
Pathology

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Perineural invasion is an independent predictor of outcome in colorectal cancer. / Liebig, Catherine; Ayala, Gustavo; Wilks, Jonathan; Verstovsek, Gordana; Liu, Hao; Agarwal, Neeti; Berger, David H.; Albo, Daniel.

In: Journal of Clinical Oncology, Vol. 27, No. 31, 01.11.2009, p. 5131-5137.

Research output: Contribution to journalArticle

Liebig, C, Ayala, G, Wilks, J, Verstovsek, G, Liu, H, Agarwal, N, Berger, DH & Albo, D 2009, 'Perineural invasion is an independent predictor of outcome in colorectal cancer', Journal of Clinical Oncology, vol. 27, no. 31, pp. 5131-5137. https://doi.org/10.1200/JCO.2009.22.4949
Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. Journal of Clinical Oncology. 2009 Nov 1;27(31):5131-5137. https://doi.org/10.1200/JCO.2009.22.4949
Liebig, Catherine ; Ayala, Gustavo ; Wilks, Jonathan ; Verstovsek, Gordana ; Liu, Hao ; Agarwal, Neeti ; Berger, David H. ; Albo, Daniel. / Perineural invasion is an independent predictor of outcome in colorectal cancer. In: Journal of Clinical Oncology. 2009 ; Vol. 27, No. 31. pp. 5131-5137.
@article{6c4707674a6a463ca69d2cc833986eca,
title = "Perineural invasion is an independent predictor of outcome in colorectal cancer",
abstract = "Purpose: Perineural invasion (PNI) is associated with decreased survival in several malignancies, but its significance in colorectal cancer (CRC) remains to be clearly defined. We evaluated PNI as a potential prognostic indicator in CRC, focusing on its significance in node-negative patients. Patients and Methods: We identified 269 consecutive patients who had CRC resected at our institution. Tumors were rereviewed for PNI by a pathologist blinded to the patients' outcomes. Overall and disease-free survivals were determined using the Kaplan-Meier method, with differences determined by multivariate analysis using the Cox multiple hazards model. Results were compared using the log-rank test. Results: PNI was identified in less than 0.5{\%} of the initial pathology reports. On rereview, 22{\%} of tumors in our series were found to be PNI positive. The 5-year disease-free survival rate was four-fold greater for patients with PNI-negative tumors versus those with PNI-positive tumors (65{\%} v 16{\%}, respectively; P < .0001). The 5-year overall survival rate was 72{\%} for PNI-negative tumors versus 25{\%} for PNI-positive tumors. On multivariate analysis, PNI was an independent prognostic factor for both cancer-specific overall and disease-free survival. In a subset analysis comparing patients with node-negative disease with patients with stage III disease, the 5-year disease-free survival rate was 56{\%} for stage III patients versus 29{\%} for patients with node-negative, PNI-positive tumors (P = .0002). Similar results were seen for overall survival. Conclusion: PNI is grossly underreported in CRC and could serve as an independent prognostic factor of outcomes in these patients. PNI should be considered when stratifying CRC patients for adjuvant treatment.",
author = "Catherine Liebig and Gustavo Ayala and Jonathan Wilks and Gordana Verstovsek and Hao Liu and Neeti Agarwal and Berger, {David H.} and Daniel Albo",
year = "2009",
month = "11",
day = "1",
doi = "10.1200/JCO.2009.22.4949",
language = "English (US)",
volume = "27",
pages = "5131--5137",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "31",

}

TY - JOUR

T1 - Perineural invasion is an independent predictor of outcome in colorectal cancer

AU - Liebig, Catherine

AU - Ayala, Gustavo

AU - Wilks, Jonathan

AU - Verstovsek, Gordana

AU - Liu, Hao

AU - Agarwal, Neeti

AU - Berger, David H.

AU - Albo, Daniel

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Purpose: Perineural invasion (PNI) is associated with decreased survival in several malignancies, but its significance in colorectal cancer (CRC) remains to be clearly defined. We evaluated PNI as a potential prognostic indicator in CRC, focusing on its significance in node-negative patients. Patients and Methods: We identified 269 consecutive patients who had CRC resected at our institution. Tumors were rereviewed for PNI by a pathologist blinded to the patients' outcomes. Overall and disease-free survivals were determined using the Kaplan-Meier method, with differences determined by multivariate analysis using the Cox multiple hazards model. Results were compared using the log-rank test. Results: PNI was identified in less than 0.5% of the initial pathology reports. On rereview, 22% of tumors in our series were found to be PNI positive. The 5-year disease-free survival rate was four-fold greater for patients with PNI-negative tumors versus those with PNI-positive tumors (65% v 16%, respectively; P < .0001). The 5-year overall survival rate was 72% for PNI-negative tumors versus 25% for PNI-positive tumors. On multivariate analysis, PNI was an independent prognostic factor for both cancer-specific overall and disease-free survival. In a subset analysis comparing patients with node-negative disease with patients with stage III disease, the 5-year disease-free survival rate was 56% for stage III patients versus 29% for patients with node-negative, PNI-positive tumors (P = .0002). Similar results were seen for overall survival. Conclusion: PNI is grossly underreported in CRC and could serve as an independent prognostic factor of outcomes in these patients. PNI should be considered when stratifying CRC patients for adjuvant treatment.

AB - Purpose: Perineural invasion (PNI) is associated with decreased survival in several malignancies, but its significance in colorectal cancer (CRC) remains to be clearly defined. We evaluated PNI as a potential prognostic indicator in CRC, focusing on its significance in node-negative patients. Patients and Methods: We identified 269 consecutive patients who had CRC resected at our institution. Tumors were rereviewed for PNI by a pathologist blinded to the patients' outcomes. Overall and disease-free survivals were determined using the Kaplan-Meier method, with differences determined by multivariate analysis using the Cox multiple hazards model. Results were compared using the log-rank test. Results: PNI was identified in less than 0.5% of the initial pathology reports. On rereview, 22% of tumors in our series were found to be PNI positive. The 5-year disease-free survival rate was four-fold greater for patients with PNI-negative tumors versus those with PNI-positive tumors (65% v 16%, respectively; P < .0001). The 5-year overall survival rate was 72% for PNI-negative tumors versus 25% for PNI-positive tumors. On multivariate analysis, PNI was an independent prognostic factor for both cancer-specific overall and disease-free survival. In a subset analysis comparing patients with node-negative disease with patients with stage III disease, the 5-year disease-free survival rate was 56% for stage III patients versus 29% for patients with node-negative, PNI-positive tumors (P = .0002). Similar results were seen for overall survival. Conclusion: PNI is grossly underreported in CRC and could serve as an independent prognostic factor of outcomes in these patients. PNI should be considered when stratifying CRC patients for adjuvant treatment.

UR - http://www.scopus.com/inward/record.url?scp=70449707511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449707511&partnerID=8YFLogxK

U2 - 10.1200/JCO.2009.22.4949

DO - 10.1200/JCO.2009.22.4949

M3 - Article

VL - 27

SP - 5131

EP - 5137

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 31

ER -